Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D. Wiviott, Marc S. Sabatine, Thomas A. Zelniker et al.|New England Journal of Medicine|2018Cited by 6.3k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial InfarctionMarc P. Bonaca, Marc S. Sabatine, Deepak L. Bhatt et al.|New England Journal of Medicine|2015Cited by 2k
Rivaroxaban in Peripheral Artery Disease after RevascularizationMarc P. Bonaca, William R. Hiatt|New England Journal of Medicine|2020Cited by 966
Vorapaxar in the Secondary Prevention of Atherothrombotic EventsDavid A. Morrow, Sabina A. Murphy, Eugene Braunwald et al.|New England Journal of Medicine|2012Cited by 941
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery DiseaseMarc P. Bonaca, Marc S. Sabatine, Patrice Nault et al.|Circulation|2017Cited by 754